C11 ER176 PET in Evaluating Neuroinflammation in Patients With Post-COVID Syndrome

ConditionCOVID-19

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorMayo Clinic

About this trial

The purpose of this research is to find out if Positron Emission Tomography (PET) imaging with an investigational drug called C-11 ER176 can help us learn more about Post-COVID Syndrome.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Mayo Clinic patients with a previously confirmed infection with the novel SARS-CoV-2 virus who have been seen in the Post COVID Clinic through GIM Integrative Medicine & Health Section or approval by MAGPIES research group.

Be able to participate fully in all aspects of the study.

Have understood and signed study informed consent.

Disqualifiers

Lacking the capacity to consent.

Prisoners and institutionalized individuals.

Reports being currently pregnant, lactating, or are of child-bearing potential or are likely to become pregnant during the LLLT treatment phase and are unwilling to use a reliable form of contraception.

Hormonal methods, such as birth control pills, patches, injections, vaginal ring, or implants

Trial population

Patients from the Post Covid Care Clinic (PCoCC) through GIM Integrative Medicine \& Health Section or approval by MAGPIES research group.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

C11 ER176 Tracer
Drug
C11 ER176 tracer will be administered by IV, followed by PET imaging of the brain to evaluate for neuroinflammation

Treatment groups

10 Participants

are divided into 1 treatment group

Group A: Post Covid Syndrome1 intervention

Trial outcomes

Primary outcomes

Degree of Neuroinflammation

Estimation of areas degree of neuroinflammation determined by the radiologist

Time frame

Baseline reading only

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Mayo Clinic

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: